Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. (Q44953303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

William W Hauswirth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

H Rubin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

M Lukason

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

J Ardinger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

E DuFresne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

S C Wadsworth

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A Scaria

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

17 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

10-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18633446%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2008.115

10 January 2020

exact match

0 references

cites work

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Ranibizumab for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

VEGF-Trap: a VEGF blocker with potent antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Gene transfer into the mouse retina mediated by an adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Gene therapy for inherited retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Adeno-associated virus gene transfer to mouse retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Commentary: an aye for eye gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

Identification of the extracellular domains of Flt-1 that mediate ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115

inferred from DOI database lookup

7 January 2021

based on heuristic

Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.115